High-content screening for the discovery of pharmacological compounds: Advantages, challenges and potential benefits of recent technological developments

Expert Opinion on Drug Discovery

Volumn 5, Issue 2, 2010, Pages 135-144

  Soleilhac, Emmanuelle ^a   Nadon, Robert ^a,b   Lafanechere, Laurence ^a  

^a CNRS   (France)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Data reduction; High content analysis; High content screening; Single cell analysis; Spheroids

Indexed keywords

NEW DRUG;

BIOINFORMATICS; BIOTECHNOLOGY; CELL ASSAY; DRUG RESEARCH; DRUG SCREENING; HIGH CONTENT SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; IMAGE ANALYSIS; MATHEMATICS; MEDICAL TECHNOLOGY; MICROSCOPY; PRIORITY JOURNAL; RELIABILITY; REVIEW;

EID: 75449117290     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440903544456     Document Type: Review

References (86)

1. Evans NA, Facci L, Owen DE, et al. A beta (1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis. J Neurosci Methods 2008;175(1):96-103
2. Viero C, Kraushaar U, Ruppenthal S, et al. A primary culture system for sustained expression of a calcium sensor in preserved adult rat ventricular myocytes. Cell Calcium 2008;43(1):59-71
3. Prigozhina NL, Zhong L, Hunter EA, et al. Plasma membrane assays and three-compartment image cytometry for high content screening. Assay Drug Dev Technol 2007;5(1):29-48
4. Mouchet EH, Simpson PB. High-content assays in oncology drug discovery: opportunities and challenges. IDrugs 2008;11(6):422-427
5. Bickle M. High-content screening: a new primary screening tool? IDrugs 2008;11(11):822-826
6. Fox S, Farr-Jones S, Sopchak L, et al. High-throughput screening: update on practices and success. J Biomol Screen 2006;11(7):864-869
7. Mayr LM, Bojanic D. Novel trends in high-throughput screening. Curr Opin Pharmacol 2009;9(5):580-588
8. Stein RL. High-throughput screening in academia: the Harvard experience. J Biomol Screen 2003;8(6):615-619
9. Inglese J, Johnson RL, Simeonov A, et al. High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 2007;3(8):466-479
10. Stockwell BR. Exploring biology with small organic molecules. Nature 2004;432(7019):846-854
11. Lafanechere L. Chemogenomics and cancer chemotherapy: cell-based assays to screen for small molecules that impair microtubule dynamics. Comb Chem High Throughput Screen 2008;11(8):617-623
12. Mitchison T. Toward pharmacological genetics. Chem Biol 1994;1:3-6
13. Fonrose X, Ausseil F, Soleilhac E, et al. Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Res 2007;67(7):3371-3378
14. Korn K, Krausz E. Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol 2007;11(5):503-510
15. Yarrow JC, Feng Y, Perlman ZE, et al. Phenotypic screening of small molecule libraries by high throughput cell imaging. Comb Chem High Throughput Screen 2003;6(4):279-286
16. Knight ZA, Shokat KM. Features of selective kinase inhibitors. Chem Biol 2005;12(6):621-637
17. Schoonen WG, Westerink WM, Horbach GJ. High-throughput screening for analysis of in vitro toxicity. EXS 2009;99:401-452
18. Giuliano KA. High-content profiling of drug-drug interactions: cellular targets involved in the modulation of microtubule drug action by the antifungal ketoconazole. J Biomol Screen 2003;8(2):125-135
19. Ross-Macdonald P, de Silva H, Guo Q, et al. Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Mol Cancer Ther 2008;7(11):3490-3498
20. Wermuth CG. Selective optimization of side activities: the SOSA approach. Drug Discov Today 2006;11(3-4):160-164
21. Caldwell GW, Ritchie DM, Masucci JA, et al. The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery. Curr Top Med Chem 2001;1(5):353-366
22. Guillouzo A, Guguen-Guillouzo C. Evolving concepts in liver tissue modeling and implications for in vitro toxicology. Expert Opin Drug Metab Toxicol 2008;4(10):1279-1294
23. Eglen RM, Gilchrist A, Reisine T. An overview of drug screening using primary and embryonic stem cells. Comb Chem High Throughput Screen 2008;11(7):566-572
24. Chen S, Borowiak M, Fox JL, et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol 2009;5(4):258-265
25. Jaksch M, Munera J, Bajpai R, et al. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 2008;68(19):7882-7886
26. Damoiseaux R, Sherman SP, Alva JA, et al. Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells 2009;27(3):533-542
27. Peterson JR, Mitchison TJ. Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem Biol 2002;9(12):1275-1285
28. Feng Y, Mitchison TJ, Bender A, et al. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds. Nat Rev Drug Discov 2009;8(7):567-578
29. Mayer TU, Kapoor TM, Haggarty SJ, et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999;286(5441):971-974
30. Stockwell BR, Haggarty SJ, Schreiber SL. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem Biol 1999;6(2):71-83
31. Crews CM, Spittgerber U. Chemical genetics: exploring and controlling cellular processes with chemical probes. Trends Biochem Sci;24:317-320
32. Burdine L, Kodadek T. Target identification in chemical genetics: the (often) missing link. Chem Biol 2004;11(5):593-597
33. Peterson JR, Lokey RS, Mitchison TJ, Kirschner MW. A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. Proc Natl Acad Sci USA 2001;98(19):10624-10629
34. Carey KL, Westwood NJ, Mitchison TJ, Ward GE. A small-molecule approach to studying invasive mechanisms of Toxoplasma gondii. Proc Natl Acad Sci USA 2004;101(19):7433-7438
35. Roberge M, Cinel B, Anderson HJ, et al. Cell-based screen for antimitotic agents and identification of analogues of rhizoxin, eleutherobin, and paclitaxel in natural extracts. Cancer Res 2000;60(18):5052-5058
36. An WF, Tolliday NJ. Introduction: cell-based assays for high-throughput screening. Methods Mol Biol 2009;486:1-12
37. Clemons PA. Complex phenotypic assays in high-throughput screening. Curr Opin Chem Biol 2004;8(3):334-338
38. Li X, Shen F, Zhang Y, et al. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay. Eur J Pharm Biopharm 2007;67(1):284-292
39. Vassal E, Barette C, Fonrose X, et al. Miniaturization and validation of a sensitive multiparametric cell-based assay for the concomitant detection of microtubule-destabilizing and microtubule-stabilizing agents. J Biomol Screen 2006;11(4):377-389
40. Bradley J, Gill J, Bertelli F, et al. Development and automation of a 384-well cell fusion assay to identify inhibitors of CCR5/CD4-mediated HIV virus entry. J Biomol Screen 2004;9(6):516-524
41. Perlman ZE, Mitchison TJ, Mayer TU. High-content screening and profiling of drug activity in an automated centrosome-duplication assay. Chembiochem 2005;6(1):145-151
42. Yarrow JC, Totsukawa G, Charras GT, Mitchison TJ. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. Chem Biol 2005;12(3):385-395
43. Yarrow JC, Perlman ZE, Westwood NJ, Mitchison TJ. A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC Biotechnol 2004;4:21
44. Gasparri F, Ciavolella A, Galvani A. Cell-cycle inhibitor profiling by high-content analysis. Adv Exp Med Biol 2007;604:137-148
45. Wilson CJ, Si Y, Thompsons CM, et al. Identification of a small molecule that induces mitotic arrest using a simplified high-content screening assay and data analysis method. J Biomol Screen 2006;11(1):21-28
46. Castel D, Pitaval A, Debily MA, Gidrol X. Cell microarrays in drug discovery. Drug Discov Today 2006;11(13-14):616-622
47. Mitchison TJ. Small-molecule screening and profiling by using automated microscopy. Chembiochem 2005;6(1):33-39
48. Loo LH, Lin HJ, Steininger RJ III, et al. An approach for extensibly profiling the molecular states of cellular subpopulations. Nat Methods 2009;6(10):759-765
49. Chakraborty C, Hsu CH, Wen ZH, Lin CS. Recent advances of fluorescent technologies for drug discovery and development. Curr Pharm Des 2009;15(30):3552-3570
50. Wolff M, Wiedenmann J, Nienhaus GU, et al. Novel fluorescent proteins for high-content screening. Drug Discov Today 2006;11(23-24):1054-1060
51. Tsui M, Xie T, Orth JD, et al. An intermittent live cell imaging screen for siRNA enhancers and suppressors of a kinesin-5 inhibitor. PLoS One 2009;4(10):e7339
52. Daub A, Sharma P, Finkbeiner S. High-content screening of primary neurons: ready for prime time. 0Curr Opin Neurobiol 2009;19:537-543
53. Neumann B, Held M, Liebel U, et al. High-throughput RNAi screening by time-lapse imaging of live human cells. Nat Methods 2006;3(5):385-390
54. Zhou X, Cao X, Perlman Z, Wong ST. A computerized cellular imaging system for high content analysis in Monastrol suppressor screens. J Biomed Inform 2006;39(2):115-125
55. Zhou X, Wong ST. Informatics challenges of high-troughput microscopy. Ieee Signal Processing Magazine 2006;23:63-72
56. Carpenter AE. Image-based chemical screening. Nat Chem Biol 2007;3(8):461-465
57. Maloney KN, Fujita M, Eggert US, et al. Actin-Aggregating Cucurbitacins from Physocarpus capitatus. J Nat Prod 2008;71:1927-1929
58. Peters U, Cherian J, Kim JH, et al. Probing cell-division phenotype space and Polo-like kinase function using small molecules. Nat Chem Biol 2006;2(11):618-626
59. Eggert US, Kiger AA, Richter C, et al. Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets. PLoS Biol 2004;2(12):e379
60. Miron M, Nadon R. Inferential literacy for experimental high-throughput biology. Trends Genet 2006;22(2):84-89
61. Malo N, Hanley JA, Cerquozzi S, et al. Statistical practice in high-throughput screening data analysis. Nat Biotechnol 2006;24(2):167-175
62. Spencer SL, Gaudet S, Albeck JG, et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009;459(7245):428- 432
63. Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003;55(2):61-70
64. Irish JM, Hovland R, Krutzik PO, et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004;118(2):217-228
65. Krutzik PO, Crane JM. High-content single-cell drug screening with phosphospecific flow cytometry. Orthopedics 2008;31(10)
66. Chen CS, Mrksich M, Huang S, et al. Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog 1998;14(3):356-363
67. Thery M, Racine V, Piel M, et al. Anisotropy of cell adhesive microenvironment governs cell internal organization and orientation of polarity. Proc Natl Acad Sci USA 2006;103(52):19771-19776
68. Thery M, Pepin A, Dressaire E, et al. Cell distribution of stress fibres in response to the geometry of the adhesive environment. Cell Motil Cytoskeleton 2006;63(6):341-355
69. Peris L, Thery M, Faure J, et al. Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends. J Cell Biol 2006;174(6):839-849
70. Thery M, Jimenez-Dalmaroni A, Racine V, et al. Experimental and theoretical study of mitotic spindle orientation. Nature 2007;447(7143):493-496
71. Kwon M, Godinho SA, Chandhok NS, et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 2008;22(16):2189-2203
72. Lamb J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 2007;7(1):54-60
73. Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006;313(5795):1929-1935
74. Zhang SD, Gant TW. A simple and robust method for connecting small-molecule drugs using gene-expression signatures. BMC Bioinformatics 2008;9:258
75. Perlman ZE, Slack MD, Feng Y, et al. Multidimensional drug profiling by automated microscopy. Science 2004;306(5699):1194-1198
76. Young DW, Bender A, Hoyt J, et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 2008;4(1):59-68
77. Loo LH, Wu LF, Altschuler SJ. Image-based multivariate profiling of drug responses from single cells. Nat Methods 2007;4(5):445-453
78. Wang J, Zhou X, Bradley PL, et al. Cellular phenotype recognition for high-content RNA interference genome-wide screening. J Biomol Screen 2008;13(1):29-39
79. Peterson RT, Link BA, Dowling JE, Schreiber SL. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 2000;97(24):12965-12969
80. Giacomotto J, Pertl C, Borrel C, et al. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy. Hum Mol Genet 2009;18(21):4089-4101
81. Kritzer JA, Hamamichi S, McCaffery JM, et al. Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models. Nat Chem Biol 2009;5(9):655-663
82. Peterson RT, Shaw SY, Peterson TA, et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 2004;22(5):595-599
83. Serebriiskii I, Castello-Cros R, Lamb A, et al. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol 2008;27(6):573-585
84. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc 2009;4(3):309-324
85. Pickl M, Ries CH. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 2009;28(3):461-468
86. Cheng K, Lai Y, Kisaalita WS. Three-dimensional polymer scaffolds for high throughput cell-based assay systems. Biomaterials 2008;29(18):2802-2812